Asbestosis is regulated by Rac1-mediated mitochondrial H2O2 levels
Asbestosis is regulated by Rac1-mediated mitochondrial H2O2 levels
批准号:
8686841
负责人:
A BRENT CARTER
金额:
$37.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-10 至 2015-02-24
关键词:
Alveolar MacrophagesAsbestosAsbestosisAttenuatedBindingBinding ProteinsBreathingC-terminalCell physiologyCellsCicatrixComplexCoupledCysteineDataDevelopmentElectron TransportFamilyFibrosisGenerationsGoalsGuanosineHydrogen PeroxideImmuneLinkLungLung diseasesMediatingMitochondriaMolecularMutationOxidation-ReductionOxidative StressOxygenPathway interactionsPatientsPlayProcessProductionPulmonary FibrosisRegulationResearchRoleSecondary toSignal TransductionSmall Interfering RNASourceStructureStructure of parenchyma of lungTherapeuticTransgenic Micecancer therapycatalasecell typecytochrome cfightinggeranylgeranylationin vivoinhibitor/antagonistmacrophagemembermutantnovelparticlepreventreceptorrhorho GTP-Binding Proteinstripolyphosphate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Asbestosis is an important type of pulmonary fibrosis. The development of pulmonary fibrosis is a complex process that is poorly understood. The generation of ROS, particularly H2O2, from alveolar macrophages plays an integral role in the development of pulmonary fibrosis as administration of catalase attenuates fibrosis. However, the source and molecular mechanism(s) that regulate asbestos-induced H2O2 generation in alveolar macrophages is not known. Rac1 is a member of the Rho family of GTP-binding proteins, and it regulates several cellular functions, including H2O2 production. Rac1 has been shown to indirectly increase mitochondrial ROS; however, no mechanism(s) by which Rac1 directly modulates mitochondrial H2O2 generation in macrophages have been described. Our data demonstrate that Rac1 is localized in the mitochondria of alveolar macrophages obtained from asbestosis patients and that Rac1 import required the C-terminal cysteine residue (cys-189), which is modified by geranylgeranylation. Geranylgeranyltransferase inhibitors (GGTI) have been used in cancer therapy, but their use in preventing pulmonary fibrosis has not been investigated. We also found that cys-178 is critical for H2O2 generation as a mutant (C178S) attenuates H2O2 levels to a similar degree as C189S. In the mitochondrial intermembrane space (IMS), Rac1 interacts with cytochrome c, which is regulated by its redox state via transfer of electrons. The macrophage receptor with collagenous structure (MARCO) is known to provide innate immune defense against inhaled particles. Alveolar macrophages obtained from asbestosis patients express significantly more MARCO compared to normal subjects, but MARCO expression is not known to be linked to mitochondrial oxidative stress. The interaction of Rac1 signaling and the PI3K/Akt pathway may positively or negatively modulate each other. No studies have investigated PI3K/Akt in the regulation of Rac1-mediated mitochondrial H2O2 generation. We found that over expression of a constitutive active Akt enhances Rac1 import into mitochondria. These observations suggest a novel, mechanistic pathway linking MARCO, PI3K/Akt, and Rac1 import into the mitochondria where it interacts with cytochrome c to generate ROS, which is coupled to pulmonary fibrosis. Hypothesis: the import of Rac1 into the mitochondria in alveolar macrophages is pivotal in generating oxidative stress and mediating pulmonary fibrosis and is modulated by MARCO, PI3K/Akt, and geranylgeranylation. In Aim 1, we will investigate if geranylgeranylation of Rac1 is necessary for mitochondrial import and if Rac1-mediated H2O2 in mitochondria is secondary to electron transfer from cytochrome c to cys-178 in Rac1. In Aim 2, we will investigate if asbestos binds on MARCO and modulates Rac1 import and if PI3K/Akt regulate geranylgeranylation of Rac1. In Aim 3, we will investigate if transgenic mice with a conditional C178S or C189S mutation in macrophage Rac1 are protected from pulmonary fibrosis and if inhibition of Rac1 geranylgeranylation with GGTI attenuates the development of pulmonary fibrosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3 Heavy Metals Exacerbate Lower Respiratory Tract Infections
-
批准号:10560544
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2020
-
负责人:A BRENT CARTER
-
依托单位:
Project 3 Heavy Metals Exacerbate Lower Respiratory Tract Infections
-
批准号:10337089
-
项目类别:
-
资助金额:$18.05万
-
财政年份:2020
-
负责人:A BRENT CARTER
-
依托单位:
Pulmonary fibrosis is modulated by MCU-mediated macrophage apoptosis resistance
-
批准号:10417027
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:A BRENT CARTER
-
依托单位:
Pulmonary fibrosis is modulated by MCU-mediated macrophage apoptosis resistance
-
批准号:10754498
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:A BRENT CARTER
-
依托单位:
Asbestosis is regulated by Rac1-mediated mitochondrial H2O2 levels
-
批准号:9060666
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2015
-
负责人:A BRENT CARTER
-
依托单位:
Asbestosis is regulated by Rac1-mediated mitochondrial H2O2 levels
-
批准号:9098706
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2015
-
负责人:A BRENT CARTER
-
依托单位:
Metabolic Regulation of Pro-Fibrotic Macrophages in Pulmonary Fibrosis
-
批准号:10218253
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2013
-
负责人:A BRENT CARTER
-
依托单位:
Cu,Zn-SOD, MMP-9, and Asbestosis
-
批准号:8413385
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:A BRENT CARTER
-
依托单位:
Cu,Zn-SOD, MMP-9, and Asbestosis
-
批准号:8598025
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:A BRENT CARTER
-
依托单位:
Cu,Zn-SOD, MMP-9, and Asbestosis
-
批准号:8243005
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:A BRENT CARTER
-
依托单位:
Lung Macrophage Metabolic Reprogramming in Asbestos-Induced Toxicity
-
批准号:10376784
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
Asbestosis is regulated by Rac1-mediated mitochondrial H2O2 levels
-
批准号:8370635
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
Lung Inflammation and Fibrosis After Asbestosis Exposure is Regulated by Rac1
-
批准号:8092539
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
Hydrogen Peroxide and Asbestosis
-
批准号:8197540
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
Hydrogen Peroxide and Asbestosis
-
批准号:7523920
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
Lung Macrophage Metabolic Reprogramming in Asbestos-Induced Toxicity
-
批准号:9889125
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
REGULATION OF ALVEOLAR MACROPHAGE FUNCTION IN ASBESTOSIS
-
批准号:7604819
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
Hydrogen Peroxide and Asbestosis
-
批准号:7371704
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
Lung Inflammation and Fibrosis After Asbestosis Exposure is Regulated by Rac1
-
批准号:7494950
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
Lung Inflammation and Fibrosis After Asbestosis Exposure is Regulated by Rac1
-
批准号:7337191
-
项目类别:
-
资助金额:$42.71万
-
财政年份:2007
-
负责人:A BRENT CARTER
-
依托单位:
海外基金